KRYSTEXXA® (Pegloticase) is a drug used in the treatment of severe, refractory, chronic gout. It metabolizes uric acid to allantoin making it more water soluble increasing its excretion. Administration of KRYSTEXXA® is by a bi-weekly intravenous infusion.
KRYSTEXXA® is manufactured by Horizon.
Quick Rx can provide medications and help schedule infusions through its affiliated company, Specialty Infusion Centers. In addition, our highly specialized pharmacists work closely with nurse practitioners to offer initial and ongoing clinical monitoring. For further questions, please call 212-2infuse (212-246-3873)